Mees D. Egeler
Amsterdam, NH, Netherlands
Last Updated: 09/26/2026
Save publications for later
Sign Up
Not sure about your diagnosis?
Check Your Symptoms
Found 15 publications
Chemotherapy duration and patient-reported outcomes in HER2-positive early breast cancer: Results from the TRAIN-3 study.
Journal: European journal of cancer (Oxford, England : 1990)
Published: April 03, 2026
Long-term cognitive function after treatment with immune checkpoint inhibition for melanoma.
Journal: Journal of cancer survivorship : research and practice
Published: December 03, 2025
MRI-based personalisation of neoadjuvant chemotherapy duration in HER2-positive early breast cancer (TRAIN-3): primary results from a multicentre, single-arm, phase 2 study.
Journal: The Lancet. Oncology
Published: September 29, 2025
Managing Cancer and Living Meaningfully (CALM) for Patients With Metastatic Cancer and Treatment Response.
Journal: Psycho-oncology
Published: September 29, 2025
Cross-sectional study of long-term Health-Related Quality of Life in stage III melanoma patients receiving neo-adjuvant versus adjuvant immune checkpoint inhibitors.
Journal: European journal of cancer (Oxford, England : 1990)
Published: April 05, 2025
The association between pretreatment emotional distress and response to tumor-infiltrating lymphocyte therapy in advanced melanoma.
Journal: European journal of cancer (Oxford, England : 1990)
Published: March 31, 2025
Health-related quality of life of patients with metastatic melanoma treated with tumor-infiltrating lymphocytes compared with ipilimumab in a randomized phase III trial.
Journal: Annals of oncology : official journal of the European Society for Medical Oncology
Published: November 11, 2024
Capturing the true effect of anti-PD-1 therapy on patients' health-related quality of life.
Journal: The Lancet. Oncology
Published: October 14, 2024
Understanding quality of life issues in patients with advanced melanoma: Phase 1 and 2 in the development of the EORTC advanced melanoma module.
Journal: European journal of cancer (Oxford, England : 1990)
Published: May 02, 2024
Survival is not enough: understanding the mental burden of cutaneous melanoma.
Journal: The British journal of dermatology
Published: January 29, 2024
Real-world health-related quality of life outcomes for patients with resected stage III/IV melanoma treated with adjuvant anti-PD1 therapy.
Journal: European journal of cancer (Oxford, England : 1990)
Published: November 16, 2023
Health-state utilities in long-term advanced melanoma survivors comparable with the general population.
Journal: Quality of life research : an international journal of quality of life aspects of treatment, care and rehabilitation
Published: April 16, 2023
Last Updated: 09/26/2026